Last 9.60 INR
Change Today +0.20 / 2.13%
Volume 12.0K
ALPA On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 04/21/14 All times are local (Market data is delayed by at least 15 minutes).

alpa laboratories ltd (ALPA) Snapshot

Open
9.49
Previous Close
9.40
Day High
9.85
Day Low
8.95
52 Week High
01/10/14 - 14.10
52 Week Low
06/13/13 - 5.10
Market Cap
202.0M
Average Volume 10 Days
7.8K
EPS TTM
-2.08
Shares Outstanding
21.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALPA LABORATORIES LTD (ALPA)

Related News

No related news articles were found.

alpa laboratories ltd (ALPA) Related Businessweek News

No Related Businessweek News Found

alpa laboratories ltd (ALPA) Details

Alpa Laboratories Limited manufactures and markets pharmaceutical finished dosage forms to various pharmaceutical companies primarily in India. The company offers approximately 400 formulations in various finished dosage forms, including liquid injections, boluses, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams, and gels for human and veterinary uses. Its products include ethical, generic, and over the counter drugs, as well as veterinary products. The company provides products in various categories, such as anti-infectives comprising antibacterial, antibiotic, antifungal, antiprotozoans, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular products; anti-diabetics; nutritional supplements; psychotropic drugs; skin care preparations; and ear and eye care preparations. It sells its products through distributors, as well as through retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to various countries in South and Central America, Africa, and Asia, including CIS countries comprising Russia, Ukraine, Kazakhstan, etc. Alpa Laboratories Limited was incorporated in 1988 and is based in Indore, India.

Founded in 1988

alpa laboratories ltd (ALPA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

alpa laboratories ltd (ALPA) Key Developments

Alpa Laboratories Ltd Appoints Mayank Lashkari as the Company Secretary and Compliance Officer

Alpa Laboratories Ltd. has informed that Mr. Mayank Lashkari, Member of The Institute of Company Secretaries of India has been appointed as the Company Secretary and Compliance Officer of the company and he has already assumed his responsibilities.

Alpa Laboratories Ltd Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Alpa Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported net sales/income from operations of INR 143.772 million compared to INR 116.855 million a year ago. Profit from operations before other income and finance costs was INR 3.404 million compared to loss from operations before other income and finance costs of INR 13.044 million a year ago. Profit from ordinary activities before tax was INR 0.361 million compared to loss from ordinary activities before tax of INR 18.141 million a year ago. Net loss from ordinary activities after tax was INR 0.639 million or INR 0.03 per basic and diluted share against net loss from ordinary activities before tax of INR 18.141 million or INR 0.86 per basic and diluted share a year ago. For the nine months, the company reported net sales/income from operations of INR 368.170 million compared to INR 363.412 million a year ago. Loss from operations before other income and finance costs was INR 33.390 million compared to loss from operations before other income and finance costs of INR 7.516 million a year ago. Loss from ordinary activities before tax was INR 38.597 million compared to loss from ordinary activities before tax of INR 16.919 million a year ago. Net loss from ordinary activities after tax was INR 40.077 million or INR 1.90 per basic and diluted share against net loss from ordinary activities before tax of INR 17.695 million or INR 0.84 per basic and diluted share a year ago.

Alpa Laboratories Ltd, Board Meeting, Feb 12, 2014

Alpa Laboratories Ltd, Board Meeting, Feb 12, 2014. Agenda: To consider quarterly results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPA:IN 9.60 INR +0.20

ALPA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALPA.
View Industry Companies
 

Industry Analysis

ALPA

Industry Average

Valuation ALPA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 0.2x
Price/Cash Flow 8.0x
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALPA LABORATORIES LTD, please visit www.alpalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.